Chungnam National University researchers reveal how vitamin D is shown to reduce liver damage by boosting TXNIP activity in cholangiocytes
A new study uncovers how vitamin D activates the TXNIP gene in ductular cells to reduce inflammation and fibrosis in chronic liver disease
2025-07-28
(Press-News.org)
Chronic liver disease (CLD) is a major global health concern, affecting approximately 1.5 billion people. This life-threatening disease often progresses silently, eventually leading to worsened conditions like liver cirrhosis or liver cancer. There is currently no treatment for CLD other than liver transplantation.
Vitamin D is commonly consumed for enhanced bone health. This study opens exciting possibilities for repurposing an inexpensive supplement as a complementary therapy for liver diseases. Prof. Hyo-Jung Kwon from the College of Veterinary Medicine, Chungnam National University in Daejeon, Republic of Korea, and his colleagues have studied the underlying mechanisms and therapeutic implications of Vitamin D in liver disease. “Here, we explored the effects of vitamin D on ductular reaction and CLDs, and investigated underlying mechanisms. Our data reveal that vitamin D supplementation ameliorates ductular reaction and reduces liver inflammation and fibrosis largely through TXNIP,” comments Prof. Kwon. Their study was published online on 13 May 2025, in Nature Communications.
Ductular reaction refers to the proliferation of ductular cells (primarily cholangiocytes) in response to liver injury. While initially protective, excessive or prolonged ductular reaction contributes to inflammation and fibrosis. In this study, researchers observed that lower plasma levels of vitamin D were associated with more severe ductular reaction in patients with CLD.
Vitamin D upregulates the expression of TXNIP (Thioredoxin-interacting protein). This was confirmed in a mouse study where Txnip deletion in cholangiocytes promoted ductular reaction and even exacerbated liver inflammation and fibrosis. In vitro analysis revealed the Vitamin D/TXNIP molecular axis. “Furthermore, Txnip deficiency increases TNF-α and TGF-β secretion by cholangiocytes to stimulate Kupffer cells and hepatic stellate cells, consequently leading to inflammation and collagen deposition,” adds Prof. Kwon.
Research that supports early diagnosis and better treatment for CLD is not only warranted but essential. “Our preclinical data reveal a new mechanism by which vitamin D supplementation ameliorates CLDs and support the idea that the vitamin D/TXNIP axis could be a promising therapeutic target in clinically addressing the ductular reaction and CLDs,” comments Prof. Kwon. Further research is needed to validate the clinical application of vitamin D supplementation as a standard supportive therapy for patients with chronic liver disease.
Ultimately, this work could improve outcomes for millions worldwide by offering safer and more personalized liver disease therapies.
***
Reference
DOI: 10.1038/s41467-025-59724-z
About the institute
Chungnam National University (CNU), located in Daejeon, South Korea, is a leading national university renowned for its excellence in research and education. Established in 1952, CNU offers diverse programs in engineering, medicine, sciences, and the arts, fostering innovation and global collaboration. Situated near Daedeok Innopolis, a major R&D hub, it excels in biotechnology, materials science, and information technology. With a vibrant international community and cutting-edge facilities, CNU continues to drive academic and technological advancements, making it a top choice for students worldwide.
Website: https://plus.cnu.ac.kr/html/en/
About the author
Prof. Hyo-Jung Kwon is a Professor of College of Veterinary Medicine, Chungnam National University. She is studying the underlying mechanisms of liver and metabolic diseases, including hepatic steatosis, inflammation, fibrosis/cirrhosis, tumors, obesity, and diabetes. She is also trying to develop specific murine models of liver diseases to mimic human patients. Her ultimate goal is to pioneer in 'bench to bedside' translational research and improve the quality of life for patients.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-07-28
University research is where innovative technological breakthroughs originate. As a result, a number of proactive universities provide substantial resources and support to their academic researchers to help increase the number of all ventures. However, despite receiving this extensive support and having access to the best scientific knowledge, many academic entrepreneurs are not as successful as their corporate counterparts. While this sounds like a contradiction, there is enough empirical evidence explaining just why this could be happening.
With this in mind, Professor Alex Coad from the Waseda Business School, Waseda University, Japan, critically analyzes the differences ...
2025-07-28
Consider the delicate web of fat in a Wagyu steak. The “marbling” that makes carnivore connoisseurs swoon is a visual heuristic for quality flavor.
Now, a new study suggests the very same marbling of fat inside our own muscles points to trouble.
This condition, known as intramuscular adipose tissue, or IMAT, has long been recognized by scientists as a strong indicator of poor health. It’s linked to a wide range of diseases: obesity, Type 2 diabetes, neuromuscular disorders (including Duchenne muscular dystrophy) and neurogenerative conditions such as ALS. In some cases, ...
2025-07-28
More than 11,000 additional women opted for the most effective form of birth control—long-acting reversible contraception (LARC)—within just 15 months of B.C. making prescription contraception free.
The numbers don’t lie
New research from the University of British Columbia and collaborators shows a 49-per-cent jump in LARC dispensations after the province introduced universal, no-cost coverage in April 2023. That’s a seismic shift in how reproductive-aged women are managing their reproductive choice, the researchers say. The study tracked ...
2025-07-28
Australian researchers have discovered a promising new strategy to suppress the growth of aggressive and hard-to-treat cancers by targeting a specialised molecular process known as ‘minor splicing’.
Published in EMBO Reports, the study shows that blocking minor splicing can markedly slow tumour growth in liver, lung and stomach cancers, while leaving healthy cells largely unharmed.
The research in animal models and human cells, from Australian medical research institute WEHI, demonstrates ...
2025-07-28
Researchers at the University of Michigan have illuminated a complete sensory pathway showing how the skin communicates the temperature of its surroundings to the brain.
This discovery, believed to be the first of its kind, reveals that cool temperatures get their own pathway, indicating that evolution has created different circuits for hot and cold temperatures. This creates an elegant solution for ensuring precise thermal perception and appropriate behavioral responses to environmental changes, said Bo Duan, senior author of the new study.
"The skin is the body's ...
2025-07-28
The largest genetic analysis of stuttering has demonstrated a clear genetic basis for the speech disorder, highlighting neurological pathways of risk. The study, published July 28 in the journal Nature Genetics, used data representing more than 1 million individuals who had their DNA analyzed by the company 23andMe Inc.
The findings point to 57 distinct genomic loci associated with stuttering and suggest a shared genetic architecture of stuttering with autism, depression and musicality. The results provide a foundation for additional research that could lead to earlier identification or therapeutic advances in stuttering. More broadly, improving understanding of the causes ...
2025-07-28
Researchers at the University of Birmingham have developed a powerful new method to detect harmful blue-green algae in freshwater lakes. Their method, which involves advanced mass spectrometry technology, can identify toxin producing blue-green algae before they become damaging in recreational waters and pose threat to public health.
Blue-green algae (scientifically named as cyanobacteria) are micro-organisms commonly found in ponds, lakes, and oceans worldwide. In optimum growth conditions, they can form huge “blooms” that appear like green slime covering the surface of the water.
Although these blooms are extremely ...
2025-07-28
Scientists at the University of California, Davis, used artificial intelligence to help plants recognize a wider range of bacterial threats — which may lead to new ways to protect crops like tomatoes and potatoes from devastating diseases. The study was published in Nature Plants.
Plants, like animals, have immune systems. Part of their defense toolkit includes immune receptors, which give them the ability to detect bacteria and defend against it. One of those receptors, called FLS2, helps plants recognize flagellin — a protein in the tiny tails bacteria use to swim. But bacteria are sneaky and constantly ...
2025-07-28
Toronto, Canada – A new study of 3,500 Canadians aged 55 and older revealed a strong association between early childhood adversities and depression. Experiencing physical abuse in childhood was linked to a threefold increase in the likelihood of lifetime depression, while exposure to sexual abuse or parental domestic violence more than doubled the risk.
The University of Toronto research was published recently in Archives of Gerontology and Geriatrics Plus.
“Our findings shine a light on how trauma in the earliest years can echo through decades, shaping patterns of mental health and well-being,” says the first author, Megha Goel, a doctoral student at the University ...
2025-07-28
Immersing in virtual reality (VR) nature scenes helped relieve symptoms that are often seen in people living with long-term pain, with those who felt more present experiencing the strongest effects.
A new study led by the University of Exeter, published in the journal Pain, tested the impact of immersive 360-degree nature films delivered using VR compared with 2D video images in reducing experience of pain, finding VR almost twice as effective.
Long-term (chronic) pain typically lasts more than three months and is particularly difficult to treat. The researchers simulated this type of pain in healthy participants, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Chungnam National University researchers reveal how vitamin D is shown to reduce liver damage by boosting TXNIP activity in cholangiocytes
A new study uncovers how vitamin D activates the TXNIP gene in ductular cells to reduce inflammation and fibrosis in chronic liver disease
